Почетна › Колоректален карцином › Охајо › Cleveland
Клинички испитувања за Колоректален карцином во Cleveland, OH
24 студии за Колоректален карцином бараат учесници на локации во и околу Cleveland (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
The Vanguard Study: Testing a New Way to Screen for Cancer
Се регрутираДобредојдени се здрави волонтери
- Louis Stokes Cleveland VA Medical Center, Cleveland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Се регрутираФаза 1/2
- The Cleveland Clinic Taussig Cancer Center, Cleveland
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Се регрутираФаза 2
- Cleveland Clinic - Oncology Department, Cleveland
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Се регрутираФаза 1
- Exelixis Clinical Site #10, Cleveland
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Се регрутираФаза 3
- University Hospitals Cleveland Medical Center, Cleveland
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Се регрутираФаза 3
- University Hospital of Cleveland, Cleveland
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Се регрутираФаза 3
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Cancer Center Fairview Hospital Moll Pavilion, Cleveland
- Taussig Cancer Insititute Cleveland Clinic, Cleveland
- и уште 2
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Се регрутираФаза 1/2
- Cleveland Clinic, Cleveland
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Се регрутираФаза 3
- Case Comprehensive Cancer Center, Cleveland
Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
Се регрутира
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Се регрутираФаза 1
- Cleveland Clinic Foundation, Cleveland
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Се регрутираФаза 3
- Clinical Study Site, Cleveland
- Clinical Study Site, Cleveland
- Clinical Study Site, Mayfield Heights · на 12 милји
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Се регрутираФаза 1
- Cleveland Clinic, Cleveland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Се регрутираФаза 1/2
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
- Cleveland Clinic, Cleveland
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Се регрутираФаза 1/2
- Cleveland Clinic, Cleveland
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Се регрутираФаза 1/2
- Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Се регрутираФаза 1
- University Hospitals - UH Cleveland Medical Center, Cleveland
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Се регрутираФаза 1
- Cleveland Clinic, Taussig Cancer Institute, Cleveland
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
Се регрутираНабљудувачка студија
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1/2
- Cleveland Clinic, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Cleveland Clinic, Cleveland
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
Се регрутираФаза 1/2
- Cleveland Clinic Foundation, Cleveland
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Се регрутираФаза 1
- Cleveland Clinic, Cleveland
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Се регрутираФаза 1/2
- Cleveland Clinic, Cleveland
Испитувања за Колоректален карцином во други градови
- Houston, TX102 студии
- New York City, NY78 студии
- Nashville, TN69 студии
- Boston, MA63 студии
- Los Angeles, CA59 студии
- Arlington, VA52 студии
- St. Louis, MO50 студии
- San Antonio, TX46 студии
- Philadelphia, PA44 студии
- Grand Rapids, MI40 студии
- Baldwin Park, CA37 студии
- Chicago, IL34 студии
Други студии во Cleveland
- Рак на бели дробови со не-мали клетки43 студии
- Рак (сите типови)36 студии
- Рак на дојка35 студии
- Рак на простата34 студии
- Срцева слабост33 студии
- Карцином на јајниците30 студии
- Метастатски карцином30 студии
- Рак на бели дробови26 студии
- Кардиоваскуларни болести22 студии
- Рак на ендометриумот20 студии
- Акутна миелоидна леукемија20 студии
- Кронова болест19 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.